Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.180
-0.018 (-1.50%)
May 21, 2026, 1:13 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 408.29 million as of May 21, 2026. Its market cap has increased by 16.09% in one year.
Market Cap
408.29M
Enterprise Value
263.03M
Revenue
19.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.18
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 408.29M, an increase of 375.89%. That is a compound annual growth rate of 18.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 408.29M | 29.65% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 790.74M |
| Infant Bacterial Therapeutics AB | 740.93M |
| Oncopeptides AB | 676.73M |
| FluoGuide | 671.96M |
| Corline Biomedical AB | 467.78M |
| Ascelia Pharma AB | 393.26M |
| Sprint Bioscience AB | 379.86M |
| Mendus AB | 346.01M |